文献速递冠心病

0/1小时算法早期诊断心肌梗死的前瞻性验证

Prospective Validation of the 0/1-h Algorithm for Early Diagnosis of Myocardial Infarction.
PubMed 文献 · J Am Coll Cardiol · 2018-01-01

本研究在6国前瞻性纳入疑似NSTEMI的急诊患者,用高敏肌钙蛋白T/I按ESC 0/1-h算法分诊。NSTEMI患病率17%;hs-cTnT组排除阴性预测值99.8%、纳入阳性预测值74.5%;hs-cTnI组分别为99.7%和62.3%,证实该算法安全有效。

要点

  • ESC 0/1-h算法用hs-cTnT/I可安全快速排除NSTEMI,阴性预测值近99.8%。
  • 该算法1小时内可将约四分之三(hs-cTnT)或三分之二以上(hs-cTnI)患者分诊。
  • 胸痛发作≤3小时早期就诊者的排除安全性在亚组分析中同样得到确认。

核心结论

  • ESC 0/1-h算法使用hs-cTnT和hs-cTnI对疑似NSTEMI患者分诊非常安全且有效。

研究设计与样本

  • 前瞻性、多中心研究,在6个国家纳入未经选择的急诊疑似NSTEMI患者。
  • 最终诊断由2名独立心内科医生集中裁定。
  • 在就诊时和1小时后测量hs-cTnT与hs-cTnI血浓度。

主要发现

  • NSTEMI患病率为17%。
  • hs-cTnT组4368例中,排除阴性预测值99.8%(2493例中2488例),纳入阳性预测值74.5%(768例中572例)。
  • hs-cTnT组57%(2493/4368)被排除、18%(768/4368)被纳入。
  • hs-cTnI组3500例中,排除阴性预测值99.7%(1533例中1528例),纳入阳性预测值62.3%(800例中498例)。
  • hs-cTnI组44%(1533/3500)被排除、23%(800/3500)被纳入。

关键数值与推荐

  • 排除安全性以NSTEMI阴性预测值量化,纳入准确性以阳性预测值量化,总体效能以1小时内分诊至排除或纳入的比例衡量。
  • 胸痛发作≤3小时早期就诊者的亚组分析确认排除安全性良好。

临床怎么用

  • 对疑似NSTEMI的急诊患者,可采用ESC 0/1-h算法结合hs-cTnT或hs-cTnI进行快速排除与纳入分诊。
  • 该算法可在1小时内对多数患者完成分诊,有助于提高急诊胸痛处理效率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The safety of the European Society of Cardiology (ESC) 0/1-h algorithm for rapid rule-out and rule-in of non-ST-segment elevation myocardial infarction (NSTEMI) using high-sensitivity cardiac troponin (hs-cTn) has been questioned. OBJECTIVES: This study aimed to validate the diagnostic performance of the 0/1-h algorithm in a large multicenter study. METHODS: The authors prospectively enrolled unselected patients in 6 countries presenting to the emergency department with symptoms suggestive of NSTEMI. Final diagnosis was centrally adjudicated by 2 independent cardiologists. Hs-cTnT and hs-cTnI blood concentrations were measured at presentation and after 1 h. Safety of rule-out was quantified by the negative predictive value (NPV) for NSTEMI, accuracy of rule-in by the positive predictive value (PPV), and overall efficacy by the proportion of patients triaged towards rule-out or rule-in within 1 h. RESULTS: Prevalence of NSTEMI was 17%. Among 4,368 patients with serial hs-cTnT measurements available, safety of rule-out (NPV 99.8%, 2,488 of 2,493), accuracy of rule-in (PPV 74.5%, 572 of 768), and overall efficacy were high by assigning three-fourths of patients either to rule-out (57%, 2,493 to 4,368) or rule-in (18%, 768 to 4,368). Similarly, among 3,500 patients with serial hs-cTnI measurements, safety of rule-out (NPV 99.7%, 1,528 of 1,533), accuracy of rule-in (PPV 62.3%, 498 of 800), and overall efficacy were high by assigning more than two-thirds of patients either to rule-out (44%, 1,533 of 3,500) or rule-in (23%, 800 of 3,500). Excellent safety was confirmed in multiple subgroup analyses including patients presenting early (≤3 h) after chest pain onset. CONCLUSIONS: The ESC 0/1-h algorithm using hs-cTnT and hs-cTnI is very safe and effective in triaging patients with suspected NSTEMI. (Advantageous Predictors of Acute Coronary Syndromes Evaluation [APACE]; NCT00470587; and Biomarkers in Acute Cardiac Care [BACC]; NCT02355457).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Twerenbold R, Neumann JT, Sörensen NA, et al. Prospective Validation of the 0/1-h Algorithm for Early Diagnosis of Myocardial Infarction. J Am Coll Cardiol. 2018. PMID: 30071991. doi:10.1016/j.jacc.2018.05.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。